Overview A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects Status: Terminated Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and efficacy of Vitreosolve in diabetic retinopathy patients. Phase: Phase 2/Phase 3 Details Lead Sponsor: Vitreoretinal Technologies, Inc.